295 related articles for article (PubMed ID: 27223121)
21. SMARCB1/INI1 tumor suppressor gene is frequently inactivated in epithelioid sarcomas.
Modena P; Lualdi E; Facchinetti F; Galli L; Teixeira MR; Pilotti S; Sozzi G
Cancer Res; 2005 May; 65(10):4012-9. PubMed ID: 15899790
[TBL] [Abstract][Full Text] [Related]
22. Prognostic determinants in epithelioid sarcoma.
Gasparini P; Facchinetti F; Boeri M; Lorenzetto E; Livio A; Gronchi A; Ferrari A; Massimino M; Spreafico F; Giangaspero F; Forni M; Maestro R; Alaggio R; Pilotti S; Collini P; Modena P; Sozzi G
Eur J Cancer; 2011 Jan; 47(2):287-95. PubMed ID: 20932739
[TBL] [Abstract][Full Text] [Related]
23. Reduced expression of SMARCB1/INI1 protein in synovial sarcoma.
Kohashi K; Oda Y; Yamamoto H; Tamiya S; Matono H; Iwamoto Y; Taguchi T; Tsuneyoshi M
Mod Pathol; 2010 Jul; 23(7):981-90. PubMed ID: 20305614
[TBL] [Abstract][Full Text] [Related]
24. The diagnostic utility of reduced immunohistochemical expression of SMARCB1 in synovial sarcomas: a validation study.
Ito J; Asano N; Kawai A; Yoshida A
Hum Pathol; 2016 Jan; 47(1):32-7. PubMed ID: 26520417
[TBL] [Abstract][Full Text] [Related]
25. SMARCB1-deficient Vulvar Neoplasms: A Clinicopathologic, Immunohistochemical, and Molecular Genetic Study of 14 Cases.
Folpe AL; Schoolmeester JK; McCluggage WG; Sullivan LM; Castagna K; Ahrens WA; Oliva E; Biegel JA; Nielsen GP
Am J Surg Pathol; 2015 Jun; 39(6):836-49. PubMed ID: 25651469
[TBL] [Abstract][Full Text] [Related]
26. Loss of INI1 expression is characteristic of both conventional and proximal-type epithelioid sarcoma.
Hornick JL; Dal Cin P; Fletcher CD
Am J Surg Pathol; 2009 Apr; 33(4):542-50. PubMed ID: 19033866
[TBL] [Abstract][Full Text] [Related]
27. Infrequent SMARCB1/INI1 gene alteration in epithelioid sarcoma: a useful tool in distinguishing epithelioid sarcoma from malignant rhabdoid tumor.
Kohashi K; Izumi T; Oda Y; Yamamoto H; Tamiya S; Taguchi T; Iwamoto Y; Hasegawa T; Tsuneyoshi M
Hum Pathol; 2009 Mar; 40(3):349-55. PubMed ID: 18973917
[TBL] [Abstract][Full Text] [Related]
28. Role of fine needle aspiration cytology in the diagnosis of a rare case of a poorly differentiated synovial sarcoma with "Rhabdoid" features, including treatment implications.
Rekhi B; Shetty O; Ramadwar M; Rangarajan V; Bajpai J
Diagn Cytopathol; 2017 Jul; 45(7):662-667. PubMed ID: 28345284
[TBL] [Abstract][Full Text] [Related]
29. Cytomorphologic Spectrum of SMARCB1-Deficient Soft Tissue Neoplasms.
Schaefer IM; Al-Ibraheemi A; Qian X
Am J Clin Pathol; 2021 Jul; 156(2):229-245. PubMed ID: 33608696
[TBL] [Abstract][Full Text] [Related]
30. Fluorescence in Situ Hybridization (FISH) for Differential Diagnosis of Soft Tissue Sarcomas.
Asif A; Mushtaq S; Hassan U; Akhtar N; Hussain M; Azam M; Qazi R
Asian Pac J Cancer Prev; 2018 Mar; 19(3):655-660. PubMed ID: 29580035
[TBL] [Abstract][Full Text] [Related]
31. Spectrum of cytopathologic features of epithelioid sarcoma in a series of 7 uncommon cases with immunohistochemical results, including loss of INI1/SMARCB1 in two test cases.
Rekhi B; Singh N
Diagn Cytopathol; 2016 Jul; 44(7):636-42. PubMed ID: 27145123
[TBL] [Abstract][Full Text] [Related]
32. Malignant rhabdoid tumors of the vulva versus epithelioid sarcomas: a clinicopathologic, immunohistochemical, and molecular genetics study.
Espinosa I; D'Angelo E; De Brot L; Prat J
Hum Pathol; 2023 May; 135():1-10. PubMed ID: 36863690
[TBL] [Abstract][Full Text] [Related]
33. [Pathological and molecular features of malignancies underlined by BAF complexes inactivation].
Le Quang M; Ranchère-Vince D; Le Loarer F
Ann Pathol; 2019 Dec; 39(6):399-413. PubMed ID: 31255411
[TBL] [Abstract][Full Text] [Related]
34. Extraskeletal myxoid chondrosarcoma with non-EWSR1-NR4A3 variant fusions correlate with rhabdoid phenotype and high-grade morphology.
Agaram NP; Zhang L; Sung YS; Singer S; Antonescu CR
Hum Pathol; 2014 May; 45(5):1084-91. PubMed ID: 24746215
[TBL] [Abstract][Full Text] [Related]
35. INI1-deficient tumors: diagnostic features and molecular genetics.
Hollmann TJ; Hornick JL
Am J Surg Pathol; 2011 Oct; 35(10):e47-63. PubMed ID: 21934399
[TBL] [Abstract][Full Text] [Related]
36. Timing of Smarcb1 and Nf2 inactivation determines schwannoma versus rhabdoid tumor development.
Vitte J; Gao F; Coppola G; Judkins AR; Giovannini M
Nat Commun; 2017 Aug; 8(1):300. PubMed ID: 28824165
[TBL] [Abstract][Full Text] [Related]
37. Epithelioid Sarcoma Arising in a Long-Term Survivor of an Atypical Teratoid/Rhabdoid Tumor in a Patient With Rhabdoid Tumor Predisposition Syndrome.
Baker TG; Lyons MJ; Leddy L; Parham DM; Welsh CT
Pediatr Dev Pathol; 2021; 24(2):164-168. PubMed ID: 33470921
[TBL] [Abstract][Full Text] [Related]
38. Epithelioid sarcoma is associated with a high percentage of SMARCB1 deletions.
Sullivan LM; Folpe AL; Pawel BR; Judkins AR; Biegel JA
Mod Pathol; 2013 Mar; 26(3):385-92. PubMed ID: 23060122
[TBL] [Abstract][Full Text] [Related]
39. Diagnosis of extraskeletal myxoid chondrosarcoma in the thigh using EWSR1-NR4A3 gene fusion: a case report.
Kobayashi H; Kikuta K; Sekita T; Susa M; Nishimoto K; Sasaki A; Kameyama K; Sugita S; Hasegawa T; Nakamura M; Matsumoto M; Morioka H
J Med Case Rep; 2016 Nov; 10(1):321. PubMed ID: 27832806
[TBL] [Abstract][Full Text] [Related]
40. EWSR1-fusion-negative, SMARCB1-deficient primary pulmonary myxoid sarcoma.
Agaimy A; Duell T; Morresi-Hauf AT
Pol J Pathol; 2017; 68(3):261-267. PubMed ID: 29363919
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
